The Role of Nitric Oxide and the Unfolded Protein Response in Cytokine-Induced β-Cell Death
- Kari T. Chambers1,
- Julie A. Unverferth1,
- Sarah M. Weber1,
- Ronald C. Wek2,
- Fumihiko Urano3 and
- John A. Corbett1
- 1Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri
- 2Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana
- 3Program in Gene Function and Expression, University of Massachusetts Medical School, North Worcester, Massachusetts
- Address correspondence and reprint requests to Dr. John A. Corbett, University of Alabama at Birmingham, Department of Medicine, 1530 Shel 614, 3rd Ave., S. Birmingham, AL 35294-2182. E-mail: corbettj{at}uab.edu
Abstract
OBJECTIVE—The unfolded protein response (UPR) is a conserved cellular response designed to alleviate damage and promote survival of cells experiencing stress; however, prolonged UPR activation can result in apoptotic cell death. The UPR, activated by cytokine-induced nitric oxide (NO) production, has been proposed to mediate β-cell death in response to cytokines. In this study, the role of UPR activation in cytokine-induced β-cell death was examined.
RESEARCH DESIGN AND METHODS—The effects of cytokine treatment of rat and human islets and RINm5F cells on UPR activation, NO production, and cell viability were examined using molecular and biochemical methodologies.
RESULTS—UPR activation correlates with β-cell death in interleukin (IL)-1–treated rat islets. NO mediates both cytokine-induced UPR activation and β-cell death as NO synthase inhibitors attenuate each of these IL-1–stimulated events. Importantly, cytokines and tunicamycin, a classical UPR activator, induce β-cell death by different mechanisms. Cell death in response to the classical UPR activator is associated with a 2.5-fold increase in caspase-3 activity, while IL-1 fails to stimulate caspase-3 activity. In addition, cell death is enhanced by ∼35% in tunicamycin-treated cells expressing an S51A eIF2α mutant that cannot be phosphorylated or in cells lacking PERK (protein kinase regulated by RNA/endoplasmic reticulum–like kinase). In contrast, neither the absence of PERK nor the expression of the S51A eIF2α mutant affects the levels of cytokine-induced death.
CONCLUSIONS—While cytokine-induced β-cell death temporally correlates with UPR activation, the lack of caspase activity and the ability of NO to attenuate caspase activity suggest that prolonged UPR activation does not mediate cytokine-induced β-cell death.
- ATF, activating transcription factor
- CHOP, C/EBP homologous protein
- DEA-NO, (Z)-1(N,N-diethylamino) diazen-1-ium-1,2-diolate
- ER, endoplasmic reticulum
- HMGB1, high-mobility group box 1 protein
- IFN, interferon
- IL, interleukin
- iNOS, inducible nitric oxide synthase
- IRE, inositol-requiring enzyme
- MEF, mouse embryonic fibroblast
- NMMA, NG-monomethyl-l-arginine
- NOS, nitric oxide synthase
- PERK, protein kinase regulated by RNA/ER–like kinase
- PGJ2, prostaglandin J2
- UPR, unfolded protein response
- XBP, X-box binding protein
Footnotes
-
Published ahead of print at http://diabetes.diabetesjournals.org on 10 October 2007. DOI: 10.2337/db07-0944.
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted October 2, 2007.
- Received July 11, 2007.
- DIABETES














